XHKG1501
Market cap614mUSD
Dec 27, Last price
27.10HKD
1D
0.56%
1Q
-5.57%
IPO
-2.87%
Name
Shanghai Kindly Medical Instruments Co Ltd
Chart & Performance
Profile
Shanghai Kindly Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers interventions products, which includes guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire used in percutaneous transluminal angioplasty (PTA) surgical procedures; angiography catheter used to inject and infuse contrast media and fluid; and Y-connector pack used in PTCA surgery. It also provides inflation device used to inflate the balloon of dilating the vessel or placing the stent in the vessel; manifold for single use; manifold kit; pressure bandage used to assist compression hemostasis; angiography syringe for single use; stopcocks used for pressure monitoring tubing during surgery; sterile seldinger needle used to puncture into the artery; introducer set; pressure transducer for single use; extension tube for pressure monitoring; and introducer tool kit used in percutaneous vertebroplasty. In addition, the company offers medical accessories, such as check value, needle free connector, male Luer locks, bi-stopper, Heparian cap, flush device, and flow regulator; other products, including joint intervention kit, disposable respirator masks, vaginal dilator used during a vaginal examination, foley catheter, infusion pumps, disposable automatic umbilical cord clamps, infusion connector and accessory for single use, and burette infusion sets without a needle. It serves medical device manufacturers and other customers. The company was founded in 2006 and is headquartered in Shanghai, China. Shanghai Kindly Medical Instruments Co., Ltd. is a subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
Income | ||||||||
Revenues | 752,836 28.50% | 585,883 26.08% | 464,675 29.64% | |||||
Cost of revenue | 607,438 | 473,714 | 357,956 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 145,398 | 112,169 | 106,719 | |||||
NOPBT Margin | 19.31% | 19.15% | 22.97% | |||||
Operating Taxes | 21,900 | 10,635 | 15,246 | |||||
Tax Rate | 15.06% | 9.48% | 14.29% | |||||
NOPAT | 123,498 | 101,534 | 91,473 | |||||
Net income | 156,457 18.79% | 131,713 -7.87% | 142,960 17.80% | |||||
Dividends | (40,320) | (43,680) | (47,310) | |||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 14,741 | 192 | ||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | 79,123 | 32,884 | 192 | |||||
Long-term debt | 31,312 | 32,089 | 26,616 | |||||
Deferred revenue | 16,993 | 10,949 | 13,696 | |||||
Other long-term liabilities | ||||||||
Net debt | (530,431) | (625,747) | (743,916) | |||||
Cash flow | ||||||||
Cash from operating activities | 178,146 | 180,460 | 72,756 | |||||
CAPEX | (168,839) | (243,207) | (277,828) | |||||
Cash from investing activities | (283,812) | (316,184) | (268,084) | |||||
Cash from financing activities | 8,058 | 9,722 | (31,069) | |||||
FCF | (35,842) | (85,144) | (148,195) | |||||
Balance | ||||||||
Cash | 434,396 | 528,266 | 640,550 | |||||
Long term investments | 206,470 | 162,454 | 130,174 | |||||
Excess cash | 603,224 | 661,426 | 747,490 | |||||
Stockholders' equity | 1,699,637 | 1,554,104 | 1,437,920 | |||||
Invested Capital | 1,186,926 | 939,858 | 705,314 | |||||
ROIC | 11.61% | 12.34% | 17.19% | |||||
ROCE | 8.11% | 6.98% | 7.33% | |||||
EV | ||||||||
Common stock shares outstanding | 170,864 | 168,396 | 166,796 | |||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 192,952 | 148,580 | 136,413 | |||||
EV/EBITDA | ||||||||
Interest | 3,194 | 818 | 633 | |||||
Interest/NOPBT | 2.20% | 0.73% | 0.59% |